Clincosm LogoSign in Get a demo

Carcinoma, Non-Small-Cell Lung

Showing NaN - NaN of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Worldwide (Emibetuzumab, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +58 more
Sep 6, 2019

Prostate Cancer, Breast Cancer, NSCLC Trial in Australia, United Kingdom (SBRT, Standard of Care)

Active, not recruiting
  • Prostate Cancer
  • +2 more
  • SBRT
  • Standard of Care
  • Liverpool, New South Wales, Australia
  • +29 more
Aug 20, 2019

NSCLC Trial in Worldwide (afatinib, erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Chandler, Arizona
  • +191 more
Feb 8, 2019

NSCLC Trial in United Kingdom (Afatinib (BIBW 2992))

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Afatinib (BIBW 2992)
  • Bournemouth, United Kingdom
  • +14 more
Jan 11, 2019

NSCLC Trial in Worldwide (BIBF 1120, Placebo)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • BIBF 1120
  • Placebo
  • Milano, Italy
  • +6 more
Sep 3, 2018

NSCLC, Adenocarcinoma Trial in Worldwide (Pemetrexed, BIBW 2992, Cisplatin)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Adenocarcinoma
  • Fayetteville, Arkansas
  • +132 more
Mar 9, 2018

NSCLC Trial in Worldwide (Patient Reported Outcomes)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Patient Reported Outcomes
  • Winnipeg, Manitoba, Canada
  • +109 more
Feb 6, 2018

NSCLC Trial in Worldwide (Investigator´s choice of chemo, BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Investigator´s choice of chemotherapy
  • BIBW 2992
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +97 more
Feb 15, 2017

NSCLC Trial in Canada (Afatinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Barrie, Ontario, Canada
  • +4 more
Feb 15, 2017

NSCLC Trial in Worldwide (PF-02341066)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +278 more
Nov 17, 2016

NSCLC Trial in Worldwide (PF-02341066, Pemetrexed, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Little Rock, Arkansas
  • +263 more
Oct 31, 2016

NSCLC Trial in Worldwide (, BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • placebo
  • BIBW 2992
  • Kingman, Arizona
  • +89 more
Jun 24, 2016

NSCLC Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo, Gemcitabine)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Sorafenib (Nexavar, BAY43-9006)
  • +3 more
  • Innsbruck, Austria
  • +120 more
Apr 3, 2015

NSCLC Trial in Worldwide (Cisplatin, Gemcitabine, PF-3512676)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +120 more
Mar 10, 2015

NSCLC Trial in Worldwide (PF-3512676 + Paclitaxel + Carboplatin, Paclitaxel + Carboplatin)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • PF-3512676 + Paclitaxel + Carboplatin
  • Paclitaxel + Carboplatin
  • Little Rock, Alaska
  • +190 more
Mar 10, 2015

Carcinoma, Large Cell, NSCLC, Carcinoma, Squamous Cell Trial in Worldwide (CP 751,871 (Figitumumab), Erlotinib)

Terminated
Has Results
  • Carcinoma, Large Cell
  • +3 more
  • Fort Smith, Arkansas
  • +174 more
Jul 22, 2013

Carcinoma, Non-small-cell Lung Trial in Worldwide (CP-675,206, best supportive care)

Completed
  • Carcinoma, Non-small-cell Lung
  • Bentonville, Arkansas
  • +25 more
Jun 5, 2012

Brain Tumors, NSCLC, Metastases, Tumor Trial in Worldwide (Motexafin Gadolinium)

Completed
  • Brain Neoplasms
  • +2 more
  • Motexafin Gadolinium
  • Phoenix, Arizona
  • +91 more
May 4, 2007

NSCLC Trial in Worldwide (LY900003)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Hot Springs, Arkansas
  • +104 more
Jul 18, 2006